Humana reported better-than-expected second-quarter results, with revenue rising 26.2% year on year to $40.89 billion and adjusted earnings per share of $7.61, an 8.8% beat over analyst estimates. Management reiterated its full-year adjusted EPS guidance of $9 at the midpoint and highlighted progress in operational streamlining, Stars program improvements, and member growth. The company is targeting a sustainable margin of at least 3% by 2028 and plans to prioritize higher-performing Medicare Advantage products through plan exits and benefit adjustments in 2027. Humana also announced a $900 million divestiture of its minority stake in Gentiva to fund the MaxHealth acquisition and expanded its Medicaid presence with a new contract in Illinois.
Humana IncBeat Q2 estimates and reiterated full-year EPS guidance
Acquisition funded by divestiture, indicating growth